Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Amylou Dueck"'
Autor:
Gry A. Taarnhøj, Christoffer Johansen, Henriette Lindberg, Ethan Basch, Amylou Dueck, Helle Pappot
Publikováno v:
Cancer Medicine, Vol 9, Iss 9, Pp 3078-3087 (2020)
Abstract Background Bladder cancer (BC) patients with advanced disease have poor outcomes. The use of patient‐reported outcomes (PROs) could lead to improvements in symptom management and hence quality of life (QoL). The aim of this study is to rep
Externí odkaz:
https://doaj.org/article/3bfb9e8636304f0bb60afffdc680d32e
Autor:
Jennifer Huberty, Ryan Eckert, Amylou Dueck, Heidi Kosiorek, Linda Larkey, Krisstina Gowin, Ruben Mesa
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Myeloproliferative neoplasm (MPN) patients suffer from significant symptoms, inflammation and reduced quality of life. Yoga improves these outcomes in other cancers, but this hasn’t been demonstrated in MPNs. The purpose of this
Externí odkaz:
https://doaj.org/article/219433939be54f1d95e03a9842371079
Autor:
Surbhi Sidana, Cristine Allmer, Melissa C. Larson, Amylou Dueck, Kathleen Yost, Rahma Warsame, Gita Thanarajasingam, James R. Cerhan, Jonas Paludo, S. Vincent Rajkumar, Thomas M. Habermann, Grzegorz S. Nowakowski, Yi Lin, Morie A. Gertz, Thomas Witzig, Angela Dispenzieri, Wilson I. Gonsalves, Stephen M. Ansell, Carrie A. Thompson, Shaji K. Kumar
Publikováno v:
JCO oncology practice. 18(8)
PURPOSE: Patients' concerns regarding clinical trial (CT) participation include apprehension about side effects, quality of life (QoL), financial burden, and quality of care. METHODS: We prospectively evaluated the experience of patients with multipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9b45a5e5aab7eda49be7cd21ea7c33
https://pubmed.ncbi.nlm.nih.gov/35580285
https://pubmed.ncbi.nlm.nih.gov/35580285
Autor:
Laura F. Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, Jenny Nguyen, Eli M. Soyfer, Jiarui Liu, Jane H. Chen, Nitya Mehrotra, Heidi E. Kosiorek, Amylou Dueck, Alexander Himstead, Elena Heide, Melinda Lem, Kenza El Alaoui, Eduard Mas Marin, Robyn M. Scherber, Ruben A. Mesa, Katrine L. Whiteson, Andrew Odegaard, Angela G. Fleischman
PurposeChronic inflammation is integral to Myeloproliferative Neoplasm (MPN) pathogenesis. JAK inhibitors reduce cytokine levels, but not without significant side effects. Nutrition is a low-risk approach to reduce inflammation and ameliorate symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b586601b4267a28229505086f9b43fc
https://doi.org/10.1101/2023.05.09.23289740
https://doi.org/10.1101/2023.05.09.23289740
Autor:
Gita Thanarajasingam, Paul Kluetz, Vishal Bhatnagar, Abbie Brown, Elizabeth Cathcart-Rake, Matthew Diamond, Louis Faust, Mallorie Fiero, Scott Huntington, Molly Moore Jeffery, Lee Jones, Brie Noble, Jonas Paludo, Brad Powers, Joseph S. Ross, Jessica Ritchie, Kathryn Ruddy, Sarah Schellhorn, Michelle Tarver, Amylou Dueck, Cary Gross
Publikováno v:
medRxiv
Introduction Accurate, patient-centered evaluation of physical function in patients with cancer can provide important information on the functional impacts experienced by patients both from the disease and its treatment. Increasingly, digital health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc26c413331b45815a4442ffa72a0f5
https://doi.org/10.1101/2023.03.08.23286924
https://doi.org/10.1101/2023.03.08.23286924
Autor:
Michelle Joy Naughton, David Zahrieh, Michael Gnant, Nicholas Zdenkowski, Julie Lemieux, Jun J Mao, Vesna Bjelic-Radisic, Eileen Shinn, Marija Balic, Christoph Thomssen, Jane Neisel, Manuel Ruiz-Echarri, Sibylle Loibl, Claudine Isaacs, David Cameron, Fernando Manuel Henao Carrasco, Matthew Goetz, Viktor Wette, Gustavo Werutsky, Hope Rugo, Marcus Vetter, Ling-Ming Tseng, Kathy Miller, Florian Fitzal, Juan Miguel Gil Gil, Haeseong Park, Barbro Linderholm, Emilio Bajetta, Zoneddy Dayao, Aleix Prat, Karin Ehrhardt, Otto Metzger, Amal Arahmani, Ernest Law, Ann Partridge, Lisa Carey, Alex Zoroufy, Amylou Dueck, Dominik Hlauschek, Angela DeMichele, Erica Mayer
Publikováno v:
Cancer Research. 82:P4-10
Background: Quality of life (QOL) in breast cancer patients (pts) can be greatly impacted by initial treatment and ongoing therapy, particularly if side effects and symptoms are not well tolerated. The PALLAS trial investigated whether the addition o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f2437005b23fbc8bc68537113e1f263
https://doi.org/10.1158/1538-7445.sabcs21-p4-10-01
https://doi.org/10.1158/1538-7445.sabcs21-p4-10-01
Autor:
Erica L. Mayer, Christian Fesl, Dominik Hlauschek, Laura Garcia-Estevez, Harold J. Burstein, Nicholas Zdenkowski, Viktor Wette, Kathy D. Miller, Marija Balic, Ingrid A. Mayer, David Cameron, Eric P. Winer, José Juan Ponce Lorenzo, Diana Lake, Gunda Pristauz-Telsnigg, Tufia C. Haddad, Lois Shepherd, Hiroji Iwata, Matthew Goetz, Fatima Cardoso, Tiffany A. Traina, Dhanusha Sabanathan, Urs Breitenstein, Kerstin Ackerl, Otto Metzger Filho, Karin Zehetner, Kadine Solomon, Sarra El-Abed, Kathy Puyana Theall, Dongrui Ray Lu, Amylou Dueck, Michael Gnant, Angela DeMichele
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
J Clin Oncol
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
J Clin Oncol
PURPOSE The PALLAS study investigated whether the addition of palbociclib, an oral CDK4/6 inhibitor, to adjuvant endocrine therapy (ET) improves invasive disease-free survival (iDFS) in early hormone receptor-positive (HR+), human epidermal growth fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58035b76513f583de9dc7cb2f3fc0def
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8242
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8242
Autor:
Chhiring Lama, Ronan Chaligne, Paulina Chamely, Amylou Dueck, Neville Dusaj, Ronald Hoffman, Heidi Kosiorek, Andrea Kubas-Meyer, Dan Landau, Eleni Mimitou, Sara Moein, Anna Nam, Nathaniel Omans, Neelang Parghi, Shira Rosenberg, Rona Singer Weinberg, Peter Smibert
Publikováno v:
Experimental Hematology. 111:S104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8832f5572f71e652ab7a8a05e7704e0
https://doi.org/10.1016/j.exphem.2022.07.175
https://doi.org/10.1016/j.exphem.2022.07.175
Autor:
Cinzia Solinas, Pushpamali De Silva, David Venet, Soizic Garaud, Chunyan Gu-Trantien, Florentine Hilbers, Evandro de Azambuja, Olena Werner, Lorena De la Peña, Amylou Dueck, Serena Di Cosimo, Istvan Lang, Jens Huober, Sherko Küemmel, Carsten Denkert, Roberto Salgado, Christos Sotiriou, Martine Piccart-Gebhart, Debora Fumagalli, Karen Willard-Gallo
Publikováno v:
Cancer Research. 79:3132-3132
Background: The level of immune suppression in an individual breast cancer (BC) patient is relevant for having a major benefit from treatments that act via or are directed to the immune response, such as anti-HER2 agents and immune checkpoint molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8533cd15f10723bf97dfb3a2a335612
https://doi.org/10.1158/1538-7445.am2019-3132
https://doi.org/10.1158/1538-7445.am2019-3132
Autor:
Perez, Edith, Baehner, Frederick, Butler, Steven, E. Thompson, Amylou Dueck, Jamshidian, Farid, Cherbavaz, Diana, Yoshizawa, Carl, Shak, Steven, Kaufman, Peter, Davidson, Nancy, Gralow, Julie, Asmann, Yan, Ballman, Karla
Hazard ratio for trastuzumab benefit as a continuous function of HER2 expression by RT-PCR, by HR status by local IHC. Estimate and 95 % confidence limits obtained from a Cox PH model for DRFI with a main effect for treatment arm (C versus A), a natu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0efbc805b845f44e18fc96c498a6ce5